Oncology Information System (OIS) is localized for needs of Chinese cancer centers
GUANGZHOU, China, May 3, 2012 /PRNewswire/ -- Over the last three years, cancer centers across China have embarked on an unprecedented effort to modernize and improve access to cancer management technology. In addition to sophisticated treatment and therapy planning technology, clinics and hospitals are implementing oncology information management (OIS) systems to coordinate radiotherapy department activities. Sun Yat-sen University Cancer Center (SYSUCC) is China's first cancer center to use Elekta's MOSAIQ® in the Chinese platform and is among the country's premier showcases for advanced oncology EMR solutions.
More than merely a translation of MOSAIQ into the Chinese language, Elekta worked to localize the MOSAIQ user interface, harmonizing it to the unique cultural and workflow priorities of the Chinese healthcare organization.
Celebrating its second anniversary, SYSUCC hosted Elekta's National RT New Technology Conference February 9-11. Top radiation oncology professionals from more than 30 provinces and cities attended the meeting, where they had the opportunity to see SYSUCC's expansive range of modern radiation technology, including its three Elekta Synergy® systems with VMAT capabilities, three Nucletron simulators and an afterloader, and 25 Elekta treatment planning stations. MOSAIQ is the center's newest addition and has already made a major impact by integrating and managing all department workflow and processes.
The integrated Elekta hardware and software "total" solution has optimized SYSUCC's workflow substantially, enabling SYSUCC clinicians to reduce patient waiting time for treatment from one month to 20 days, increasing patients treated from 520 per month to 600 patients, says SYSUCC Vice President, Ma Jun.
The Chinese version of MOSAIQ also is easily understood by all members of the SYSUCC staff, adds Dr. Sun Ying, Vice Director of SYSUCC.
"Effective data management across different departments and locations had been a challenge in the past," he observes. "We had to go to four different systems to schedule appointments for each patient. With MOSAIQ , we only need to find the right slot and then schedule the patient's appointment once in MOSAIQ."
A critical improvement was the ability to interface the center's HIS with MOSAIQ, reducing the need for manual entry of patient data in MOSAIQ, and facilitating accurate transfer of ADT information.
As a vendor neutral OIS, MOSAIQ has given SYSUCC's radiation oncologists the flexibility to choose the optimal tools for their patients, according to SYSUCC Director, Dr. Liu Meng Zhong.
"In addition to the freedom to integrate any technology with MOSAIQ, rapid, reliable access to patient data is vital in managing our patients' care," he says. "With the comprehensive radiation oncology chart in MOSAIQ, you can quickly find what you need when you need it."
As the anchor of its radiation oncology workflow and processes, SYSUCC's selection of MOSAIQ positions it as a leader in modern radiotherapy in China, Dr. Ying says.
"MOSAIQ is the right platform to guide us into a new era of safety and efficiency."
For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: [email protected]
Time zone: CET: Central European Time
Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: [email protected]
Time zone: ET: Eastern Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.